High prevalence and inferior long‐term outcomes for <scp>TP53</scp> mutations in therapy‐related acute lymphoblastic leukemia

Authors :: Hoda Pourhassan
Dongyun Yang
Michelle Afkhami
Raju Pillai
Brian Ball
Monzr Al Malki
Amandeep Salhotra
Haris Ali
Andrew Artz
Peter Curtin
Saro Armenian
Anthony Stein
Stephen J. Forman
Guido Marcucci
Vinod Pullarkat
Ryotaro Nakamura
Ibrahim Aldoss
Source :: American Journal of Hematology. 97
Publication Year :: 2022
Publisher :: Wiley, 2022.

Subjects :: Mutation
Prevalence
Humans
Hematology
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Tumor Suppressor Protein p53
Prognosis

Tools